India vs Kiribati: Cause of death, by non-communicable diseases, ages 0-4
India
14.7%
in 2021
Kiribati
13.4%
in 2021
India rank
132nd
Kiribati rank
135th
Cause of death, by non-communicable diseases, ages 0-4 over time
- India
- Kiribati
How they compare
India currently reports 14.7% against 13.4% in Kiribati, a difference of 1.3%.
That makes India's figure about 1.1 times Kiribati's.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Kiribati ahead.
India ranks 132nd and Kiribati ranks 135th of 185 countries.
Across the 3 decades both report, India averaged higher in 1 and Kiribati in 2.
Head to head by decade
| Decade | India | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 11.6% | 4.9% | Kiribati |
| 2010s | 11.3% | 15.2% | 3.9% | Kiribati |
| 2020s | 14.7% | 14.3% | 0.4% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, India or Kiribati?
- India, at 14.7% against 13.4% in Kiribati as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between India and Kiribati?
- 1.3%, with India ahead.
- How many years of comparable data are there for India and Kiribati?
- 6 years are reported by both, from 2000 to 2021.
- How do India and Kiribati rank globally for cause of death, by non-communicable diseases, ages 0-4?
- India ranks 132nd and Kiribati ranks 135th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.